Riskpilot← Back to searchSign inGet full accessMedVård Härryda AB
ABActiveOrg 5568213994Idrottsgatan 27 Lgh 1201General medical practice activities · NACE 8621Est. 20101-4 employees
Revenue 2024
SEK 1,4M
+14% vs 2023
EBITDA margin
11.0%
+305% vs 2023
Equity ratio
50.6%
Financial strength
Net profit 2024
SEK 118K
+292% vs 2023
| Revenue | SEK 1,4M | +14% |
| EBITDA | SEK 151K | +305% |
| Net profit | SEK 118K | +292% |
| Total assets | SEK 371K | +2% |
| Equity | SEK 188K | +34% |
| Employees | — | — |
Legal name
MedVård Härryda AB
Org number
5568213994
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
15 oktober 2010
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Registrerad kvalificerad revisor saknas.
Company purpose
Bolaget ska bedriva läkarkonsult, hälsovård och fysioterapi.
Address
Idrottsgatan 27 Lgh 1201
Email
leena.steen@outlook.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 135 | 1 233 | 1 322 | 1 206 | 1 369 |
| Staff expenses | — | — | −1 067 | −1 053 | −1 065 |
| EBITDA | 178 | 148 | 157 | 37 | 151 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 178 | 148 | 157 | 37 | 151 |
| Net financials | −3 | — | 0 | 1 | 2 |
| Profit before tax | 175 | 148 | 157 | 38 | 153 |
| Tax | −40 | −33 | −33 | −8 | −35 |
| Net profit | 135 | 115 | 124 | 30 | 118 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 396 | 370 | 435 | 364 | 371 |
| Equity | 246 | 262 | 235 | 140 | 188 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 149 | 108 | 200 | 224 | 183 |
| Total debt | 149 | 108 | 200 | 224 | 183 |
EBITDA margin
11.0%
This company
15.8%
Market median
-30% vs market
20202024
Equity ratio
50.6%
This company
38.2%
Market median
+32% vs market
20202024
Return on equity
62.6%
This company
18.4%
Market median
+240% vs market
20202024
Net profit margin
8.6%
This company
8.1%
Market median
+6% vs market
20202024
Asset turnover
3.69×
This company
1.12×
Market median
+229% vs market
20202024
Debt / equity
0.98×
This company
0.62×
Market median
+58% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MF | Audit | 2020 |
ML Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of MedVård Härryda AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Fredrik Johansson | Audit | 0 companies |
| Maria Leena Steen | Chief Executive Officer | 0 companies |
| Monica Kerstin Carita Leandersson | Deputy Board Member | 0 companies |
| Anna-Karin Pauline Steen | Board of Directors | 0 companies |